Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases

被引:59
作者
Masoodi, Tariq [1 ]
Siraj, Sarah [1 ]
Siraj, Abdul K. [1 ]
Azam, Saud [1 ]
Qadri, Zeeshan [1 ]
Parvathareddy, Sandeep K. [1 ]
Tulbah, Asma [2 ]
Al-Dayel, Fouad [2 ]
AlHusaini, Hamed [3 ]
AlOmar, Osama [4 ]
Al-Badawi, Ismail A. [4 ]
Alkuraya, Fowzan S. [5 ,6 ]
Al-Kuraya, Khawla S. [1 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Human Canc Genom Res, POB 3354, Riyadh 11211, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Dept Pathol, POB 3354, Riyadh 11211, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Med Oncol, POB 3354, Riyadh 11211, Saudi Arabia
[4] King Faisal Specialist Hosp & Res Ctr, Dept Obstet & Gynaecol, POB 3354, Riyadh 11211, Saudi Arabia
[5] King Faisal Specialist Hosp & Res Ctr, Dept Genet, POB 3354, Riyadh 11211, Saudi Arabia
[6] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh, Saudi Arabia
关键词
CANCER; SELECTION; PROGRESSION; MUTATIONS; MORTALITY; IMPACT;
D O I
10.1038/s41416-020-0763-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background High-grade serous ovarian carcinoma (HGSOC) is the most frequent type of ovarian carcinoma, associated with poor clinical outcome and metastatic disease. Although metastatic processes are becoming more understandable, the genomic landscape and metastatic progression in HGSOC has not been elucidated. Methods Multi-region whole-exome sequencing was performed on HGSOC primary tumours and their metastases (n = 33 tumour regions) from six patients. The resulting somatic variants were analysed to delineate tumour evolution and metastatic dissemination, and to compare the repertoire of events between primary HGSOC and metastasis. Results All cases presented branching evolution patterns in primary HGSOC, with three cases further showing parallel evolution in which different mutations on separate branches of a phylogenetic tree converge on the same gene. Furthermore, linear metastatic progression was observed in 67% of cases with late dissemination, in which the metastatic tumour mostly acquires the same mutational process active in primary tumour, and parallel metastatic progression, with early dissemination in the remaining 33.3% of cases. Metastatic-specific SNVs were further confirmed as late dissemination events. We also found the involvement of metastatic-specific driver events in the Wnt/beta-catenin pathway, and identified potential clinically actionable events in individual patients of the metastatic HGSOC cohort. Conclusions This study provides deeper insights into clonal evolution and mutational processes that can pave the way to new therapeutic targets.
引用
收藏
页码:1219 / 1230
页数:12
相关论文
共 53 条
[1]   Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary [J].
Ahmed, Ashour Ahmed ;
Etemadmoghadam, Dariush ;
Temple, Jillian ;
Lynch, Andy G. ;
Riad, Mohamed ;
Sharma, Raghwa ;
Stewart, Colin ;
Fereday, Sian ;
Caldas, Carlos ;
DeFazio, Anna ;
Bowtell, David ;
Brenton, James D. .
JOURNAL OF PATHOLOGY, 2010, 221 (01) :49-56
[2]   Tumor Evolution as a Therapeutic Target [J].
Amirouchene-Angelozzi, Nabil ;
Swanton, Charles ;
Bardelli, Alberto .
CANCER DISCOVERY, 2017, 7 (08) :805-817
[3]   Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma [J].
Arend, Rebecca C. ;
Londono, Angelina I. ;
Montgomery, Allison M. ;
Smith, Haller J. ;
Dobbin, Zachary C. ;
Katre, Ashwini A. ;
Martinez, Alba ;
Yang, Eddy S. ;
Alvarez, Ronald D. ;
Huh, Warner K. ;
Bevis, Kerri S. ;
Straughn, J. Michael, Jr. ;
Estes, Jacob M. ;
Novak, Lea ;
Crossman, David K. ;
Cooper, Sara J. ;
Landen, Charles N. ;
Leath, Charles A., III .
MOLECULAR CANCER RESEARCH, 2018, 16 (05) :813-824
[4]  
Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]
[5]   Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors [J].
Bao, Lei ;
Messer, Karen ;
Schwab, Richard ;
Harismendy, Olivier ;
Pu, Minya ;
Crain, Brian ;
Yost, Shawn ;
Frazer, Kelly A. ;
Rana, Brinda ;
Hasteh, Farnaz ;
Wallace, Anne ;
Parker, Barbara A. .
PLOS ONE, 2015, 10 (11)
[6]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[7]   Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer [J].
Bowtell, David D. ;
Boehm, Steffen ;
Ahmed, Ahmed A. ;
Aspuria, Paul-Joseph ;
Bast, Robert C., Jr. ;
Beral, Valerie ;
Berek, Jonathan S. ;
Birrer, Michael J. ;
Blagden, Sarah ;
Bookman, Michael A. ;
Brenton, James D. ;
Chiappinelli, Katherine B. ;
Martins, Filipe Correia ;
Coukos, George ;
Drapkin, Ronny ;
Edmondson, Richard ;
Fotopoulou, Christina ;
Gabra, Hani ;
Galon, Jerome ;
Gourley, Charlie ;
Heong, Valerie ;
Huntsman, David G. ;
Iwanicki, Marcin ;
Karlan, Beth Y. ;
Kaye, Allyson ;
Lengyel, Ernst ;
Levine, Douglas A. ;
Lu, Karen H. ;
McNeish, Iain A. ;
Menon, Usha ;
Narod, Steven A. ;
Nelson, Brad H. ;
Nephew, Kenneth P. ;
Pharoah, Paul ;
Powell, Daniel J., Jr. ;
Ramos, Pilar ;
Romero, Iris L. ;
Scott, Clare L. ;
Sood, Anil K. ;
Stronach, Euan A. ;
Balkwill, Frances R. .
NATURE REVIEWS CANCER, 2015, 15 (11) :668-679
[8]   MUTATION SELECTION AND NATURAL-HISTORY OF CANCER [J].
CAIRNS, J .
NATURE, 1975, 255 (5505) :197-200
[9]  
Casas-Selves Matias, 2011, Evolution (N Y), V4, P624
[10]   Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival [J].
Corvigno, Sara ;
Wisman, G. Bea A. ;
Mezheyeuski, Artur ;
van der Zee, Ate G. J. ;
Nijman, Hans W. ;
Avall-Lundqvist, Elisabeth ;
Ostman, Arne ;
Dahlstrand, Hanna .
ONCOTARGET, 2016, 7 (14) :18573-18584